Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Open-market sale CEO sold 29,539 shares at $65.00 ($1,920,035)
  2. 4 Open-market sale CEO sold 90,776 shares at an average $60.18 ($5,463,230)
  3. 4 Open-market sale Director sold 7,893 shares at an average $60.02 ($473,709)
  4. 4 Open-market sale Chairman sold 36,318 shares at an average $55.98 ($2,033,109)
  5. 4 Shares withheld for taxes EVP, Corp Dev, GC & Secretary gave up 1,286 shares (to pay taxes)
  6. 4 Open-market sale Chairman sold 15,000 shares at an average $54.50 ($817,552)
  7. 4 Open-market sale Chairman sold 15,000 shares at $53.61 ($804,150)
  8. 4 Open-market sale Director sold 5,000 shares at $52.89 ($264,448)
  9. 4 Open-market sale Chief Executive Officer sold 15,785 shares at $52.11 ($822,615)
  10. 4 Open-market sale Director sold 8,375 shares at $52.16 ($436,876)
  11. 4 Open-market sale Director sold 7,342 shares at $53.00 ($389,126)
  12. 4 Open-market sale Director sold 376 shares at $52.81 ($19,857)
  13. 4 Open-market sale Director sold 1,377 shares at $51.15 ($70,434)
  14. 4 Grant or award Director acquired 4,895 shares (grant or award)
  15. 4 Grant or award Director acquired 4,895 shares (grant or award)
  16. 4 Grant or award Director acquired 4,895 shares (grant or award)
  17. 4 Grant or award Director acquired 4,895 shares (grant or award)
  18. 4 Grant or award Director acquired 4,895 shares (grant or award)
  19. 4 Grant or award Director acquired 4,895 shares (grant or award)
  20. 4 Grant or award Director acquired 4,895 shares (grant or award)

Page 19 of 49 · 970 filings